Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
Cdx2
REST API REST API
Mus musculus
Cdx2 is differentially expressed in 122 experiments: 45 organism parts: liver, kidney, ... (43 more);, 5 disease states: normal, GM-CSF tumor-bearing, ... (3 more);, 24 cell types 8 cell lines 13 compound treatments and 29 other conditions.
Synonyms 'Cdx-2'
Orthologs F1N4C4_BOVIN (Bos taurus)   Cdx2 (Rattus norvegicus)   F6YJR3_CIOIN (Ciona intestinalis)   CDX2 (Homo sapiens)   cad (Drosophila melanogaster)   F1P2M4_CHICK (Gallus gallus)   cdx2 (Xenopus laevis)   (Compare orthologs)
Gene Ontology Term pattern specification process, transcriptional repressor complex, condensed nuclear chromosome, DNA binding, protein binding, regulation of transcription, DNA-dependent, double-stranded DNA binding, protein complex, transcription, DNA-dependent, positive regulation of cell proliferation, transcription corepressor activity, cell differentiation, sequence-specific DNA binding, multicellular organismal development, nucleus, somatic stem cell maintenance, negative regulation of transcription from RNA polymerase II promoter, regulation of transcription from RNA polymerase II promoter, positive regulation of transcription, DNA-dependent, labyrinthine layer development, placenta development, blood vessel development, positive regulation of cell differentiation, blastocyst development, trophectodermal cell differentiation, sequence-specific DNA binding transcription factor activity, transcription regulatory region sequence-specific DNA binding, anterior/posterior pattern specification
InterPro Term HTH_lambrepressr, Homeobox, Caudal_activation_dom, Homeobox_eu
Search EB-eye ENSMUSG00000029646
Show more properties
Experimental Factors
Organism part

studied in E-TABM-1039, E-MEXP-114, E-TABM-865, E-GEOD-20160, E-GEOD-3963, ... (34 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-21515, E-MEXP-2554

Factor Value U/D Experiments
14M1.4
1
1
E-MEXP-2554
IP14D-101
1
1
E-GEOD-21515
IP36D-3
1
E-GEOD-21515
R1
1
E-GEOD-21515
RAW264
1
E-MEXP-2554
IP14D-1
1
1
E-GEOD-21515
2 more value(s).


Cell type

studied in E-GEOD-19401, E-TABM-232, E-GEOD-7069, E-GEOD-21515, E-GEOD-21749, ... (11 experiments)

Factor Value U/D Experiments
epiblast cell
1
E-MEXP-955
spermatid
1
E-TABM-130
Th1
1
E-TABM-232
ex vivo pLN follicular dendritic cell
1
E-GEOD-19401
T regulatory cell
1
E-GEOD-1419
hematopoietic stem cell
1
E-GEOD-7069
18 more value(s).


Disease state

studied in E-GEOD-670, E-GEOD-21927, E-GEOD-21902, E-GEOD-775

Factor Value U/D Experiments
myocardial infarction
1
E-GEOD-775
sham
1
1
E-GEOD-775
GM-CSF tumor-bearing
1
1
E-GEOD-21927
normal
1
1
33
E-GEOD-21902, E-GEOD-670
tumor
1
E-GEOD-21902


Compound treatment

studied in E-TABM-141, E-TABM-363, E-GEOD-21927, E-TABM-903, E-GEOD-469, ... (10 experiments)

Factor Value U/D Experiments
cardiotoxin
2
2
E-MEXP-703, E-GEOD-469
trans-10, cis-12 conjugated linoleic acid
1
E-GEOD-4671
medium
1
E-MEXP-2209
cycloheximide (pretreatment)+ chlorophenylthio-cAMP + glucose
1
E-TABM-141
bone morphogenetic protein 4
2
1
E-TABM-363
control
2
1
E-GEOD-469, E-GEOD-4671, E-TABM-903
7 more value(s).


Amount to core

studied in E-GEOD-18858

Factor Value U/D Experiments
10
1
1
E-GEOD-18858
15
1
E-GEOD-18858
50
1
E-GEOD-18858


Cohort
studied in E-GEOD-20524, E-GEOD-4356

Developmental stage
studied in E-MEXP-2457, E-GEOD-16533, E-GEOD-8191, E-MTAB-25, E-GEOD-5831, ... (15 experiments)

dose or concentration
studied in E-GEOD-18858

Fraction
studied in E-TABM-363

Genotype
studied in E-GEOD-19684, E-GEOD-6526, E-MEXP-1649, E-TABM-285, E-GEOD-19194, ... (18 experiments)

in vivo treatment
studied in E-GEOD-18858

infection duration (days)
studied in E-GEOD-20524

infection status
studied in E-GEOD-20524

Injury
studied in E-GEOD-1999

Light
studied in E-TABM-285

Observation
studied in E-GEOD-5296

Organism
studied in E-MEXP-667

Protocol type
studied in E-GEOD-12293, E-GEOD-21389

Replicate
studied in E-GEOD-17112

Rna integrity number
studied in E-GEOD-18858

RNAi
studied in E-MEXP-1342

Route of exposure
studied in E-GEOD-18858

Sampling time point
studied in E-GEOD-4356

Sex
studied in E-MEXP-1711

Stimulus or stress
studied in E-GEOD-15894

Strain or line
studied in E-GEOD-21515, E-GEOD-21278, E-MTAB-76, E-TABM-285

Treatment
studied in E-MTAB-76, E-GEOD-21902, E-GEOD-18344, E-GEOD-21841, E-MEXP-2189 ... (5 experiments)

Treatment repeat
studied in E-GEOD-18858

Treatment time
studied in E-GEOD-18858, E-GEOD-4356

Units of amount
studied in E-GEOD-18858

Units of duration
studied in E-GEOD-18858

units of treatment repeat
studied in E-GEOD-18858

vehicle for chemical
studied in E-GEOD-18858

Processing time: 0.563 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM